Currently, TIL therapy has shown the most promise in certain cancers, such as melanoma, cervical cancer, and some forms of non-small cell lung cancer. However, ongoing research aims to expand the applicability of TIL-based therapies to a broader range of cancers, potentially offering new treatment options for many patients.
